Home › Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases
 

Keywords :   


Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases

2015-11-03 04:16:23| drugdiscoveryonline Home Page

Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics recently announced that the two companies have entered into a strategic research collaboration focused on the use of CRISPR’s gene editing technology, known as CRISPR-Cas9, to discover and develop potential new treatments aimed at the underlying genetic causes of human disease

Tags: technology develop discover establish

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »